$0.84
Live
1.38%
Downside
Day's Volatility :4.78%
Upside
3.45%
38.1%
Downside
52 Weeks Volatility :52.73%
Upside
23.64%
Period | Milestone Scientific Inc | Index (Russel 2000) |
---|---|---|
3 Months | -1.28% | 0.0% |
6 Months | 58.69% | 0.0% |
1 Year | -5.84% | 0.0% |
3 Years | -59.77% | -23.0% |
Market Capitalization | 66.2M |
Book Value | $0.10 |
Earnings Per Share (EPS) | -0.07 |
PEG Ratio | 0.0 |
Wall Street Target Price | 2.13 |
Profit Margin | -54.88% |
Operating Margin TTM | -96.04% |
Return On Assets TTM | -36.34% |
Return On Equity TTM | -59.4% |
Revenue TTM | 8.4M |
Revenue Per Share TTM | 0.11 |
Quarterly Revenue Growth YOY | -36.3% |
Gross Profit TTM | 6.3M |
EBITDA | -6.7M |
Diluted Eps TTM | -0.07 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.04 |
EPS Estimate Next Year | -0.04 |
EPS Estimate Current Quarter | -0.01 |
EPS Estimate Next Quarter | -0.01 |
What analysts predicted
Upside of 153.57%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 9.6M | ↓ 14.71% |
Net Income | -7.4M | ↑ 43.28% |
Net Profit Margin | -77.24% | ↓ 31.27% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 8.4M | ↓ 12.97% |
Net Income | -7.7M | ↑ 3.09% |
Net Profit Margin | -91.49% | ↓ 14.25% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 5.4M | ↓ 35.07% |
Net Income | -7.5M | ↓ 2.28% |
Net Profit Margin | -137.69% | ↓ 46.2% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 10.3M | ↑ 89.52% |
Net Income | -7.1M | ↓ 4.91% |
Net Profit Margin | -69.09% | ↑ 68.6% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 8.8M | ↓ 14.54% |
Net Income | -8.7M | ↑ 22.29% |
Net Profit Margin | -98.87% | ↓ 29.78% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 9.8M | ↑ 11.6% |
Net Income | -6.9M | ↓ 20.41% |
Net Profit Margin | -70.51% | ↑ 28.36% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.6M | ↑ 15.92% |
Net Income | -1.3M | ↓ 31.9% |
Net Profit Margin | -50.34% | ↑ 35.34% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.9M | ↑ 12.03% |
Net Income | -2.2M | ↑ 69.49% |
Net Profit Margin | -76.16% | ↓ 25.82% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.1M | ↓ 29.23% |
Net Income | -1.5M | ↓ 33.84% |
Net Profit Margin | -71.2% | ↑ 4.96% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.3M | ↑ 9.78% |
Net Income | -1.9M | ↑ 32.23% |
Net Profit Margin | -85.77% | ↓ 14.57% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 2.2M | ↓ 0.52% |
Net Income | -1.4M | ↓ 25.7% |
Net Profit Margin | -64.06% | ↑ 21.71% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.9M | ↓ 17.57% |
Net Income | 223.6K | ↓ 115.52% |
Net Profit Margin | 12.06% | ↑ 76.12% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 6.4M | ↓ 59.04% |
Total Liabilities | 4.9M | ↓ 40.05% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.6M | ↑ 2.43% |
Total Liabilities | 4.9M | ↑ 1.13% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 19.6M | ↑ 198.51% |
Total Liabilities | 3.5M | ↓ 29.69% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 19.8M | ↑ 1.22% |
Total Liabilities | 3.6M | ↑ 3.75% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 13.7M | ↓ 30.83% |
Total Liabilities | 3.7M | ↑ 2.82% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 11.4M | ↓ 17.01% |
Total Liabilities | 3.4M | ↓ 9.11% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 12.3M | ↓ 10.43% |
Total Liabilities | 3.0M | ↓ 18.24% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 11.2M | ↓ 9.14% |
Total Liabilities | 3.4M | ↑ 14.18% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 10.6M | ↓ 5.09% |
Total Liabilities | 3.6M | ↑ 4.08% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 11.4M | ↑ 7.45% |
Total Liabilities | 3.4M | ↓ 6.45% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 11.4M | ↓ 0.18% |
Total Liabilities | 3.9M | ↑ 15.82% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 12.0M | ↑ 5.77% |
Total Liabilities | 4.1M | ↑ 4.14% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.6M | ↑ 32.43% |
Investing Cash Flow | -15.4K | ↓ 92.26% |
Financing Cash Flow | -250.0K | ↓ 153.96% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.8M | ↑ 9.29% |
Investing Cash Flow | -9.9K | ↓ 35.7% |
Financing Cash Flow | 2.6M | ↓ 1124.82% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -7.0M | ↑ 292.57% |
Investing Cash Flow | -21.4K | ↑ 116.2% |
Financing Cash Flow | 19.7M | ↑ 669.46% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -4.0M | ↓ 42.48% |
Investing Cash Flow | -15.2K | ↓ 29.15% |
Financing Cash Flow | 4.6M | ↓ 76.8% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.0M | ↑ 83.88% |
Investing Cash Flow | -4.4M | ↓ 280.94% |
Financing Cash Flow | -2.2K | ↑ 5.05% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.0M | ↓ 48.91% |
Investing Cash Flow | 2.4M | ↓ 155.27% |
Financing Cash Flow | -2.2K | ↑ 0.0% |
Sell
Neutral
Buy
Milestone Scientific Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Milestone Scientific Inc | -11.66% | 58.69% | -5.84% | -59.77% | -33.05% |
Intuitive Surgical, Inc. | 6.56% | 41.26% | 91.18% | 53.45% | 177.85% |
Resmed Inc. | -2.51% | 33.07% | 63.68% | -8.76% | 83.88% |
Becton, Dickinson And Company | 3.84% | 4.22% | -4.76% | -1.1% | -4.07% |
Alcon Ag | -2.89% | 18.03% | 30.76% | 16.68% | 62.63% |
Cooper Companies Inc., The | -1.41% | 20.24% | -66.42% | 5.22% | 50.71% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Milestone Scientific Inc | NA | NA | 0.0 | -0.04 | -0.59 | -0.36 | NA | 0.1 |
Intuitive Surgical, Inc. | 81.54 | 81.54 | 4.08 | 6.65 | 0.16 | 0.08 | NA | 41.4 |
Resmed Inc. | 34.67 | 34.67 | 2.0 | 7.71 | 0.23 | 0.13 | 0.01 | 33.11 |
Becton, Dickinson And Company | 48.07 | 48.07 | 1.11 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
Alcon Ag | 42.58 | 42.58 | 3.58 | 3.06 | 0.05 | 0.03 | 0.0 | 42.35 |
Cooper Companies Inc., The | 59.32 | 59.32 | 11.0 | 3.66 | 0.05 | 0.03 | NA | 39.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Milestone Scientific Inc | Buy | $66.2M | -33.05% | NA | -54.88% |
Intuitive Surgical, Inc. | Buy | $168.3B | 177.85% | 81.54 | 27.65% |
Resmed Inc. | Buy | $35.2B | 83.88% | 34.67 | 21.79% |
Becton, Dickinson And Company | Buy | $69.5B | -4.07% | 48.07 | 7.13% |
Alcon Ag | Buy | $46.6B | 62.63% | 42.58 | 11.44% |
Cooper Companies Inc., The | Buy | $21.3B | 50.71% | 59.32 | 9.45% |
Insights on Milestone Scientific Inc
Revenue is down for the last 3 quarters, 2.26M → 1.85M (in $), with an average decrease of 9.0% per quarter
Netprofit is up for the last 3 quarters, -1.93M → 223.63K (in $), with an average increase of 389.4% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 95.3% return, outperforming this stock by 102.2%
In the last 3 years, Intuitive Surgical, Inc. has given 53.4% return, outperforming this stock by 113.2%
milestone scientific has developed and currently manufactures, markets and sells “computer-controlled local anesthetic delivery” (c-clad) systems for the improved and painless delivery of local anesthetic. the system is marketed in dentistry under the trademarks compudent & sta system (newest technology). sta™ system is suitable for all dental procedures. compudent™ and the more advanced sta™ system are suitable for all dental injections regularly used in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics and a number of other disciplines. compudent and the sta system is sold in the united states and worldwide in over 25 countries.
Organization | Milestone Scientific Inc |
Employees | 17 |
CEO | Mr. Jan Adriaan Haverhals |
Industry | Health Technology |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$0.84
-1.98%
Invesco Bulletshares 2025 Hi
$0.84
-1.98%
Schwab International Dividend Equity Etf
$0.84
-1.98%
Blockchain Coinvestors Acquisition Corp.
$0.84
-1.98%
Allgiant Travel Company
$0.84
-1.98%
Rogers Corp
$0.84
-1.98%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$0.84
-1.98%
Iheartmedia
$0.84
-1.98%
Lightpath Technologies Inc
$0.84
-1.98%